Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., introduces A-Gene, a best practice guide for developing and manufacturing gene therapy products. This open-source educational resource, currently being developed by ARM, is intended to be used as a reference guide for companies in gene therapy sector and aims to establishing consensus on best practice within the industry and help drive advancement. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.